What does the research say about Supernormal vascular aging?

Supernormal vascular aging

There is 1 paper on supernormal vascular aging in aging research: 1 observational study in people. The newest story, Oct 29, 2026: “Artery stiffness-based age linked to cardiovascular events”.

Biomarker

1 paper studies it18 more mention it1 finding

See all 19

“SUPERNOVA had a decrease risk (HR: 0.75; 95% CI: 0.64-0.90) of adverse clinical outcomes”

Association of Vascular Aging Phenotypes with Adverse Clinical Outcomes in the Chinese Population: A Multicentre StudyClinical interventions in aging2025doi:10.2147/cia.s485597

Humans1

Associations

Adverse clinical outcomes

downin humans1HR 0.75

1 study

Supernormal vascular aging is linked with a lower risk of adverse clinical outcomes in humans (HR 0.75, 95% CI 0.64-0.90).
“SUPERNOVA had a decrease risk (HR: 0.75; 95% CI: 0.64-0.90) of adverse clinical outcomes”
Humans11.07 yearsn = 5,316
Association of Vascular Aging Phenotypes with Adverse Clinical Outcomes in the Chinese Population: A Multicentre Study
Clinical interventions in agingMar 29, 2025

Latest

7 papers in 12 months

Journal of the American Heart AssociationJul 17

Artery stiffness-based age linked to cardiovascular events

Early vascular aging based on artery stiffness was linked to a higher cardiovascular event rate than normal vascular aging, with a hazard ratio of 1.44.Early vascular aging based on artery stiffness was linked to a higher cardiovascular event rate than normal vascular aging, with a hazard ratio of 1.44.

Cohort · 3,561 peopleCardiovascular disease